From Physicochemical Constraints to Clinical Prospects of Celastrol: Challenges and Nano Delivery Strategies
International Journal of Nanomedicine · 2025-09 · Volume 20 · 10907-10931
DOI: 10.2147/ijn.s539586 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025-09. Verfasst von Peng He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Stem Cell Regulation and Application of Traditional Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsh…. Hauptthemen laut MEDLINE: Triterpenes, Nanoparticle Drug Delivery System, Drug Delivery Systems. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Celastrol (CeT) is the first pentacyclic triterpenoid compound isolated from the root bark of Tripterygium wilfordii. It has a broad spectrum of pharmacological activities, including anti-fibrosis, anti-tumor, anti-inflammation, immunomodulation, antioxidation, and neuroprotective effects. Despite the considerable therapeutic potential, the clinical application of CeT has been severely hindered by several inherent limitations, including poor aqueous solubility and permeability, low oral bioavailability, short plasma half-life, cytotoxicity, organ toxicity and so on. In recent years, the rapid development of nanotechnology has provided innovative strategies to address these challenges. The targeted drug delivery system based on nanomaterials can improve the administration defects of CeT and enhance its therapeutic efficacy. This review systematically summarizes the challenges faced by CeT in the drug delivery process, and discusses the latest progress of nanodelivery strategies in overcoming these challenges from both active and passive targeting aspects, including the application of nanosystems such as polymer micelles, liposomes, nanoparticles and nanogels, and other nanosystems, providing references for the further development and clinical application of CeT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Stem Cell Regulation and Application of Traditional Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
- Science and Technology Innovation Center, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
- The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410007, People's Republic of China.
- Hunan Key Laboratory of Vascular Biology and Translational Medicine, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
Zitieren
APA
He, P., Sun, J., Tan, J., Shi, Y. N., Zhang, C. J., Zhu, N., Yang, Q., & Qin, L. (2025). From Physicochemical Constraints to Clinical Prospects of Celastrol: Challenges and Nano Delivery Strategies. International Journal of Nanomedicine, Volume 20, 10907-10931. https://doi.org/10.2147/ijn.s539586
Vancouver
He P, Sun J, Tan J, Shi YN, Zhang CJ, Zhu N, et al. From Physicochemical Constraints to Clinical Prospects of Celastrol: Challenges and Nano Delivery Strategies. International Journal of Nanomedicine. 2025;Volume 20:10907-10931. doi:10.2147/ijn.s539586
BibTeX
@article{He2025,
author = {He, Peng and Sun, Jing and Tan, Jian and Shi, Ya-Ning and Zhang, Chan-Juan and Zhu, Neng and Yang, Qiong and Qin, Li},
title = {From Physicochemical Constraints to Clinical Prospects of Celastrol: Challenges and Nano Delivery Strategies},
journal = {International Journal of Nanomedicine},
year = {2025},
volume = {Volume 20},
pages = {10907--10931},
doi = {10.2147/ijn.s539586}
}
EUVIMED